My point was that the weaknesses identified (after the product strengths) were not weaknesses in the product but shareholder risks in commercialising the chip. The product IP has already been commercialised - so the product does exist.
Technology due diligence, page-110
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $333.6M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.5¢ | 17.0¢ | $2.303M | 13.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 149 | 3707748 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 1173238 | 17 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| BRN (ASX) Chart |